Experimental Trypanosoma cruzi Infection and Chagas Disease—A Word of Caution
Acknowledgments
Conflicts of Interest
References
- Chagas, C. Nova tripanozomiaze humana: Estudos sobre a morfologia e o ciclo evolutivo do Schizotrypanum cruzi n.gen, s sp, ajente etiológico de nova entidade mórbida do homem. Memórias Inst. Oswaldo Cruz. 1909, 1, 159–218. [Google Scholar] [CrossRef] [Green Version]
- Vianna, G. Contribuição para o estudo da anatomia patolojica da molestia de Carlos Chagas: (Esquizotripanoze humana ou tireoidite parazitaria). Memórias Inst. Oswaldo Cruz 1911, 3, 276–294. [Google Scholar] [CrossRef] [Green Version]
- Chagas, C.; Villela, E. Cardiac form of American Trypanosomiasis. Memórias Inst. Oswaldo Cruz. 1922, 14, 5–61. [Google Scholar] [CrossRef]
- Wood, S.F. Importance of feeding and defecation times of insect vectors in transmissión of Chagas’ disease. J. Econ. Entomol. 1951, 44, 52–54. [Google Scholar] [CrossRef]
- Köberle, F. Chagas’ disease and Chagas’ syndromes: The pathology of American trypanosomiasis. Adv. Parasitol. 1968, 6, 63–116. [Google Scholar] [CrossRef]
- Talvani, A.; Rocha, M.O.; Ribeiro, A.L.; Correa-Oliveira, R.; Teixeira, M.M. Chemokine receptor expression on the surface of peripheral blood mononuclear cells in Chagas disease. J. Infect. Dis. 2004, 189, 214–220. [Google Scholar] [CrossRef]
- Cunha-Neto, E.; Chevillard, C. Chagas disease cardiomyopathy: Immunopathology and genetics. Mediat. Inflamm. 2014, 2014, 683230. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Morillo, C.A.; Marin-Neto, J.A.; Avezum, A.; Sosa-Estani, S.; Rassi, A., Jr.; Rosas, F.; Villena, E.; Quiroz, R.; Bonilla, R.; Britto, C.; et al. Randomized trial of benznidazole for chronic Chagas’ cardiomyopathy. N. Engl. J. Med. 2015, 373, 1295–1306. [Google Scholar] [CrossRef] [Green Version]
- Alonso-Vega, C.; Urbina, J.A.; Sanz, S.; Pinazo, M.J.; Pinto, J.J.; Gonzalez, V.R.; Rojas, G.; Ortiz, L.; Garcia, W.; Lozano, D.; et al. New chemotherapy regimens and biomarkers for Chagas disease: The rationale and design of the TESEO study, an open-label, randomised, prospective, phase-2 clinical trial in the Plurinational State of Bolivia. BMJ Open 2021, 11, e052897. [Google Scholar] [CrossRef]
- Koh, C.C.; Neves, E.G.A.; de Souza-Silva, T.G.; Carvalho, A.C.; Pinto, C.H.R.; Galdino, A.S.; Gollob, K.J.; Dutra, W.O. Cytokine Networks as Targets for Preventing and Controlling Chagas Heart Disease. Pathogens 2023, 12, 171. [Google Scholar] [CrossRef] [PubMed]
- Prata, A. Clinical and epidemiological aspects of Chagas disease. Lancet Infect. Dis. 2001, 1, 92–100. [Google Scholar] [CrossRef] [PubMed]
- Rocha, M.O.; Ribeiro, A.L.; Teixeira, M.M. Clinical management of chronic Chagas cardiomyopathy. Front. Biosci. 2003, 8, e44–e54. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Rassi, A., Jr.; Rassi, A.; Marin-Neto, J.A. Chagas disease. Lancet 2010, 375, 1388–1402. [Google Scholar] [CrossRef] [PubMed]
- Torres, R.M.; Correia, D.; Nunes, M.D.C.P.; Dutra, W.O.; Talvani, A.; Sousa, A.S.; Mendes, F.S.N.S.; Scanavacca, M.I.; Pisani, C.; Moreira, M.D.C.V.; et al. Prognosis of chronic Chagas heart disease and other pending clinical challenges. Memórias Inst. Oswaldo Cruz. 2022, 117, e210172. [Google Scholar] [CrossRef] [PubMed]
- Ribeiro, A.L.; Nunes, M.P.; Teixeira, M.M.; Rocha, M.O. Diagnosis and management of Chagas disease and cardiomyopathy. Nat. Rev. Cardiol. 2012, 9, 576–589. [Google Scholar] [CrossRef]
- Piras, M.M.; Piras, R.; Henriquez, D.; Negri, S. Changes in morphology and infectivity of cell culture-derived trypomastigotes of Trypanosoma cruzi. Mol. Biochem. Parasitol. 1982, 6, 67–81. [Google Scholar] [CrossRef]
- Mortara, R.A. Trypanosoma cruzi: Amastigotes and trypomastigotes interact with different structures on the surface of HeLa cells. Exp. Parasitol. 1991, 73, 1–14. [Google Scholar] [CrossRef]
- Retana Moreira, L.; Rodríguez Serrano, F.; Osuna, A. Extracellular vesicles of Trypanosoma cruzi tissue-culture cell-derived trypomastigotes: Induction of physiological changes in non-parasitized culture cells. PLoS Negl. Trop. Dis. 2019, 13, e0007163. [Google Scholar] [CrossRef] [Green Version]
- Buckner, F.S. Experimental chemotherapy and approaches to drug discovery for Trypanosoma cruzi infection. Adv. Parasitol. 2011, 75, 89–119. [Google Scholar] [CrossRef]
- Verstrepen, K.J.; Fink, G.R. Genetic and epigenetic mechanisms underlying cell-surface variability in protozoa and fungi. Annu. Rev. Genet. 2009, 43, 1–24. [Google Scholar] [CrossRef]
- Camargos, E.R.; Franco, D.J.; Garcia, C.M.; Dutra, A.P.; Teixeira, A.L., Jr.; Chiari, E.; Machado, C.R. Infection with different Trypanosoma cruzi populations in rats: Myocarditis, cardiac sympathetic denervation, and involvement of digestive organs. Am. J. Trop. Med. Hyg. 2000, 62, 604–612. [Google Scholar] [CrossRef] [Green Version]
- Silva, M.C.; Azevedo, M.A.; Figueiredo, V.P.; Moura Junior, M.R.; Coelho Junior, D.; Martinelli, P.M.; Machado, R.P.; Alzamora, A.C.; Talvani, A. Renovascular hypertension increases serum TNF and CX3CL1 in experimental Trypanosoma cruzi infection. Braz. J. Med. Biol. Res. 2018, 51, e6690. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Andrade, S.G. Influence of Trypanosoma cruzi strain on the pathogenesis of chronic myocardiopathy in mice. Memórias Inst. Oswaldo Cruz. 1990, 85, 17–27. [Google Scholar] [CrossRef] [Green Version]
- Rodriguez, H.O.; Guerrero, N.A.; Fortes, A.; Santi-Rocca, J.; Gironès, N.; Fresno, M. Trypanosoma cruzi strains cause different myocarditis patterns in infected mice. Acta Trop. 2014, 139, 57–66. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Figueiredo, V.P.; Silva, M.C.; Souza, D.M.S.; Coelho Junior, D.; Lopes, L.R.; Azevedo, M.A.; Menezes, A.P.J.; de Lima, W.G.; Peluzio, M.D.C.G.; Talvani, A. Trypanosoma cruzi infection increases atherosclerotic lesion in ApoE-deficient mice. Microb. Pathog. 2022, 171, 105730. [Google Scholar] [CrossRef] [PubMed]
- Brener, Z. Therapeutic activity and criterion of cure in mice experimentally infected with Trypanosoma cruzi. Rev. Inst. Med. Trop. 1962, 4, 389–396. [Google Scholar]
- Yoshida, N. Trypanosoma cruzi: Recognition of trypomastigote surface antigens by lytic antisera from mice resistant to acute infection. Exp. Parasitol. 1986, 61, 184–191. [Google Scholar] [CrossRef] [PubMed]
- Rottenberg, M.E.; Rodriguez, D.A.; Orn, A. Control of Trypanosoma cruzi infection in mice deprived of T-cell help. Scand. J. Immunol. 1992, 36, 261–268. [Google Scholar] [CrossRef]
- Talvani, A.; Ribeiro, C.S.; Aliberti, J.C.; Michailowsky, V.; Santos, P.V.; Murta, S.M.; Romanha, A.J.; Almeida, I.C.; Farber, J.; Lannes-Vieira, J.; et al. Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy: Tissue parasitism and endogenous IFN-gamma as important determinants of chemokine mRNA expression during infection with Trypanosoma cruzi. Microbes Infect. 2000, 2, 851–866. [Google Scholar] [CrossRef]
- Esper, L.; Roman-Campos, D.; Lara, A.; Brant, F.; Castro, L.L.; Barroso, A.; Araujo, R.R.; Vieira, L.Q.; Mukherjee, S.; Gomes, E.R.; et al. Role of SOCS2 in modulating heart damage and function in a murine model of acute Chagas disease. Am. J. Pathol. 2012, 181, 130–140. [Google Scholar] [CrossRef]
- Vera-Ku, M.; Meza-González, G.; Carlier, Y.; Truyens, C.; Gamboa-León, R. Comparison of methodologies for detecting Trypanosoma cruzi parasites by microscopic observation of microhematocrit capillary tubes. Rev. Soc. Bras. Med. Trop. 2019, 52, e20180505. [Google Scholar] [CrossRef] [PubMed]
- Carneiro, M.; Romanha, A.J.; Chiari, E. Biological characterization of Trypanosoma cruzi strains from different zymodemes and schizodemes. Memórias Inst. Oswaldo Cruz. 1991, 86, 387–393. [Google Scholar] [CrossRef] [Green Version]
- de Lana, M.; Chiari, E.; Tafuri, W.L. Experimental Chagas’ disease in dogs. Memórias Inst. Oswaldo Cruz. 1992, 87, 59–71. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- de Paula Costa, G.; Lopes, L.R.; da Silva, M.C.; Horta, A.L.; Pontes, W.M.; Milanezi, C.M.; Guedes, P.M.; de Lima, W.G.; Schulz, R.; da Silva, J.S.; et al. Doxycycline and benznidazole reduce the profile of Th1, Th2, and Th17 Chemokines and chemokine receptors in cardiac tissue from chronic Trypanosoma cruzi-infected dogs. Mediat. Inflamm. 2016, 2016, 3694714. [Google Scholar] [CrossRef] [Green Version]
- Rodríguez-Morales, O.; Roldán, F.J.; Vargas-Barrón, J.; Parra-Benítez, E.; Medina-García, M.L.; Vergara-Bello, E.; Arce-Fonseca, M. Echocardiographic findings in canine model of Chagas disease immunized with DNA Trypanosoma cruzi genes. Animals 2020, 10, 648. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wallukat, G.; Botoni, F.A.; Rocha, M.O.D.C.; Louise, V.; Müller, J.; Talvani, A. Functional antibodies against G-protein coupled receptors in Beagle dogs infected with two different strains of Trypanosoma cruzi. Front. Immunol. 2022, 13, 926682. [Google Scholar] [CrossRef]
- Lages-Silva, E.; Ramírez, L.E.; Pedrosa, A.L.; Crema, E.; da Cunha Galvão, L.M.; Pena, S.D.; Macedo, A.M.; Chiari, E. Variability of kinetoplast DNA gene signatures of Trypanosoma cruzi II strains from patients with different clinical forms of Chagas’ disease in Brazil. J. Clin. Microbiol. 2006, 44, 2167–2171. [Google Scholar] [CrossRef] [Green Version]
- Zingales, B.; Bartholomeu, D.C. Trypanosoma cruzi genetic diversity: Impact on transmission cycles and Chagas disease. Memórias Inst. Oswaldo Cruz. 2022, 117, e210193. [Google Scholar] [CrossRef]
- Cardoso, C.S.; Ribeiro, A.L.P.; Oliveira, C.D.L.; Oliveira, L.C.; Ferreira, A.M.; Bierrenbach, A.L.; Silva, J.L.P.; Colosimo, E.A.; Ferreira, J.E.; Lee, T.H.; et al. Beneficial effects of benznidazole in Chagas disease: NIH SaMi-Trop cohort study. PLoS Negl. Trop. Dis. 2018, 12, e0006814. [Google Scholar] [CrossRef] [Green Version]
- Nunes, M.C.P.; Buss, L.F.; Silva, J.L.P.; Martins, L.N.A.; Oliveira, C.D.L.; Cardoso, C.S.; Brito, B.O.F.; Ferreira, A.M.; Oliveira, L.C.; Bierrenbach, A.L.; et al. Incidence and predictors of progression to Chagas cardiomyopathy: Long-term follow-up of Trypanosoma cruzi-seropositive individuals. Circulation 2021, 144, 1553–1566. [Google Scholar] [CrossRef]
- Bestetti, R.B.; Cardinalli-Neto, A. Sudden cardiac death in Chagas’ heart disease in the contemporary era. Int. J. Cardiol. 2008, 131, 9–17. [Google Scholar] [CrossRef] [PubMed]
- Nunes, M.C.; Dones, W.; Morillo, C.A.; Encina, J.J.; Ribeiro, A.L.; Council on Chagas Disease of the Interamerican Society of Cardiology. Chagas disease: An overview of clinical and epidemiological aspects. J. Am. Coll. Cardiol. 2013, 62, 767–776. [Google Scholar] [CrossRef] [PubMed]
- de la Rosa, E.; Paglini-Oliva, P.; Prato, L.B.; Benizio, E.; Triquell, M.F.; Muñoz, S.E.; Fernández, E.A. Early Detection of Chronic Asymptomatic Chagas Infection. Med. Sci. Monit. 2018, 24, 4567–4571. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Talvani, A.; Teixeira, M.M. Experimental Trypanosoma cruzi Infection and Chagas Disease—A Word of Caution. Microorganisms 2023, 11, 1613. https://doi.org/10.3390/microorganisms11061613
Talvani A, Teixeira MM. Experimental Trypanosoma cruzi Infection and Chagas Disease—A Word of Caution. Microorganisms. 2023; 11(6):1613. https://doi.org/10.3390/microorganisms11061613
Chicago/Turabian StyleTalvani, André, and Mauro Martins Teixeira. 2023. "Experimental Trypanosoma cruzi Infection and Chagas Disease—A Word of Caution" Microorganisms 11, no. 6: 1613. https://doi.org/10.3390/microorganisms11061613
APA StyleTalvani, A., & Teixeira, M. M. (2023). Experimental Trypanosoma cruzi Infection and Chagas Disease—A Word of Caution. Microorganisms, 11(6), 1613. https://doi.org/10.3390/microorganisms11061613